Advise early-stage biotechs across business development, corporate strategy, and strategic planning.

Assessment of all strategic corporate opportunities for Shire including M&A, licensing transactions, and divestitures

Head of Finance for Business Development & Licensing group in assessing all licensing, acquisition, and collaboration opportunitiesPartner with the team in all facets of transaction process including negotiation, term sheet drafting, due diligence, approvals, and deal closureProvide forecasting, financial and structure modeling, valuation, sensitivity analysis and presentation developmentProvide financial recommendation with regards to various strategic decisions (go-no-go, opt-in, assessment of different clinical pathways, review of numerous business cases)

Managed deal teams to serve healthcare clients across Pharmaceuticals, Biotechnology, Services, and Medical Technology verticals and to offer Corporate Finance, Debt, Equity, and M&A advisory servicesDeveloped presentations, memoranda, and other materials for client management teams and Board of Directors membersDeveloped extensive financial models for returns, merger accretion-dilution, financing options, valuation, and strategic business analysesPerformed company valuations using public comparable companies analyses, precedent M&A transactions analyses, discounted cash flow models, and leveraged buyout models

Executed transactions by leading all aspects of the deal process, including financial modeling and valuation, drafting of presentations and offering memoranda, and performing financial and operational due diligence